155 related articles for article (PubMed ID: 36719467)
1. Evolution of SARS-CoV-2-specific CD4
Brand M; Keşmir C
Immunogenetics; 2023 Jun; 75(3):283-293. PubMed ID: 36719467
[TBL] [Abstract][Full Text] [Related]
2. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
[TBL] [Abstract][Full Text] [Related]
3. Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy.
Sankaranarayanan S; Mohkhedkar M; Janakiraman V
Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166432. PubMed ID: 35568352
[TBL] [Abstract][Full Text] [Related]
4. Cross-protection induced by highly conserved human B, CD4
Prakash S; Dhanushkodi NR; Zayou L; Ibraim IC; Quadiri A; Coulon PG; Tifrea DF; Suzer B; Shaik AM; Chilukuri A; Edwards RA; Singer M; Vahed H; Nesburn AB; Kuppermann BD; Ulmer JB; Gil D; Jones TM; BenMohamed L
Front Immunol; 2024; 15():1328905. PubMed ID: 38318166
[TBL] [Abstract][Full Text] [Related]
5. Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4
Tye EXC; Jinks E; Haigh TA; Kaul B; Patel P; Parry HM; Newby ML; Crispin M; Kaur N; Moss P; Drennan SJ; Taylor GS; Long HM
Nat Immunol; 2022 Dec; 23(12):1726-1734. PubMed ID: 36456735
[TBL] [Abstract][Full Text] [Related]
6. Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.
Emmelot ME; Vos M; Boer MC; Rots NY; de Wit J; van Els CACM; Kaaijk P
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891550
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 spike protein-derived immunogenic peptides that are promiscuously presented by several HLA-class II molecules and their potential for inducing acquired immunity.
Yajima Y; Kosaka A; Ohkuri T; Hirohashi Y; Li D; Nagasaki T; Nagato T; Torigoe T; Kobayashi H
Heliyon; 2023 Sep; 9(9):e20192. PubMed ID: 37809871
[TBL] [Abstract][Full Text] [Related]
10. Peptidome Surveillance Across Evolving SARS-CoV-2 Lineages Reveals HLA Binding Conservation in Nucleocapsid Among Variants With Most Potential for T-Cell Epitope Loss in Spike.
Wnuk K; Sudol J; Spilman P; Soon-Shiong P
Front Immunol; 2022; 13():918928. PubMed ID: 35812370
[TBL] [Abstract][Full Text] [Related]
11. In silico analysis of mutant epitopes in new SARS-CoV-2 lineages suggest global enhanced CD8+ T cell reactivity and also signs of immune response escape.
Pretti MAM; Galvani RG; Scherer NM; Farias AS; Boroni M
Infect Genet Evol; 2022 Apr; 99():105236. PubMed ID: 35149224
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 epitopes inform future vaccination strategies.
Shafqat A; Omer MH; Ahmad O; Niaz M; Abdulkader HS; Shafqat S; Mushtaq AH; Shaik A; Elshaer AN; Kashir J; Alkattan K; Yaqinuddin A
Front Immunol; 2022; 13():1041185. PubMed ID: 36505475
[TBL] [Abstract][Full Text] [Related]
13. Predicted HLA Class I and Class II Epitopes From Licensed Vaccines Are Largely Conserved in New SARS-CoV-2 Omicron Variant of Concern.
López D
Front Immunol; 2022; 13():832889. PubMed ID: 35154154
[TBL] [Abstract][Full Text] [Related]
14. Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2.
Becerra-Artiles A; Nanaware PP; Muneeruddin K; Weaver GC; Shaffer SA; Calvo-Calle JM; Stern LJ
PLoS Pathog; 2023 Jul; 19(7):e1011032. PubMed ID: 37498934
[TBL] [Abstract][Full Text] [Related]
15. Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants.
Ballesteros-Sanabria L; Pelaez-Prestel HF; Ras-Carmona A; Reche PA
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625733
[TBL] [Abstract][Full Text] [Related]
16. Immunoinformatics prediction of overlapping CD8
Fatoba AJ; Maharaj L; Adeleke VT; Okpeku M; Adeniyi AA; Adeleke MA
Vaccine; 2021 Feb; 39(7):1111-1121. PubMed ID: 33478794
[TBL] [Abstract][Full Text] [Related]
17. Conservation of HLA Spike Protein Epitopes Supports T Cell Cross-Protection in SARS-CoV-2 Vaccinated Individuals against the Potentially Zoonotic Coronavirus Khosta-2.
Martín-Galiano AJ; López D
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892276
[TBL] [Abstract][Full Text] [Related]
18. Development and application of EpitopeScan, a Python3 toolset for mutation tracking in SARS-CoV-2 immunogenic epitopes.
Kovalenko A; Viatte S
Front Immunol; 2024; 15():1356314. PubMed ID: 38840924
[TBL] [Abstract][Full Text] [Related]
19. Identification of HLA-A*24:02-Restricted CTL Candidate Epitopes Derived from the Nonstructural Polyprotein 1a of SARS-CoV-2 and Analysis of Their Conservation Using the Mutation Database of SARS-CoV-2 Variants.
Takagi A; Matsui M
Microbiol Spectr; 2021 Dec; 9(3):e0165921. PubMed ID: 34937174
[TBL] [Abstract][Full Text] [Related]
20.
Isaeva OI; Ketelaars SLC; Kvistborg P
Front Immunol; 2022; 13():891524. PubMed ID: 35572563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
